Companies Dominating the Bacterial Disease Diagnostics Landscape
- bioMérieux SA
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Becton, Dickinson and Company
- DiaSorin SpA (Luminex)
- Accelerate Diagnostics Inc.
- Bruker Corp.
- Danaher Corp.
- Torus Biosystems
- GENERI BIOTECH s.r.o.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of bacterial disease diagnostics is assessed at USD 3.95 billion.
The bacterial disease diagnostics market size was valued at USD 3.49 billion in 2024 and is expected to reach USD 9.38 billion by 2037, registering around 7.9% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of bacterial infection and technological advancement in diagnostic technology will boost the market growth.
North America industry is predicted to dominate majority revenue share of 35% by 2037, due to rising instances of fatal infections caused by bacteria in the region.
The major players in the market are bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, GENERI BIOTECH s.r.o.
